Aerpio Therapeutics, Inc.

Aerpio Therapeutics, Inc.

Aerpio Therapeutics, Inc.

Aerpio Therapeutics, a biotechnology company, develops new small molecules and monoclonal antibodies for the treatment of vascular disease.
Founded
2011
Raised
$49M
Follow us
Alexa global traffic share
23 Apr 2014
$22,000,000
Venture capital
30 Aug 2012
$27,000,000
Venture capital (Series A)